Primary amyloidosis with cardiac involvement diagnosed by left ventricular endomyocardial biopsy

Australian and New Zealand Journal of Medicine
|August 1, 1977
PubMed

Insights

This case study highlights primary amyloidosis, a condition causing nephrotic syndrome and heart failure. Endomyocardial biopsy proved crucial for diagnosing cardiac amyloidosis and guiding treatment.

Area of Science:

  • Cardiology
  • Nephrology
  • Oncology

Background:

  • Primary amyloidosis can manifest with nephrotic syndrome and progress to heart failure.
  • Cardiac involvement in amyloidosis often presents as a restrictive cardiomyopathy.
  • Early diagnosis is critical for managing systemic amyloidosis.

Observation:

  • A patient presented with nephrotic syndrome, followed by heart failure symptoms.
  • Hemodynamic data indicated a restrictive cardiomyopathy.
  • Left ventricular endomyocardial biopsy was performed for diagnostic evaluation.

Findings:

  • Histological examination of the endomyocardial biopsy confirmed amyloid deposition in the heart.
  • The biopsy findings were pathognomonic for cardiac amyloidosis.
  • Chemotherapy regimen included prednisone, penicillamine, melphalan, and fluoxymesterone.

Implications:

  • Endomyocardial biopsy is a definitive diagnostic tool for cardiac amyloidosis.
  • Accurate diagnosis facilitates timely and appropriate therapeutic interventions.
  • This case underscores the importance of considering amyloidosis in patients with unexplained nephrotic syndrome and heart failure.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...